INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
SEC FORM 4/Open-market saleVerified data

Hannay Michael Charles Ferguson sold BCYC

CHIEF PROD & SUPPLY CHAIN OFF · BICYCLE THERAPEUTICS PLC · Ordinary Shares

Side
SELL
Value
$1,099
Shares
255
Price
$4.31
Executed
Jul 6, 2026
Disclosed
Jul 7, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jul 6 executedJul 7, 2026 disclosed

BCYC · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
32/ 100 · ELEVATED
Methodology →
  • Transaction type+12 / 20

    Open-market sale

  • Relative size+1 / 25

    $1K reported value · 0.3% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+4 / 15

    5 prior trades recorded in this security

  • Frequency & clustering+15 / 15

    4 other actors traded the same direction within 14 days

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · BCYC

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    13
    PS
    Perry Jennifer ScottChief Operating Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale · 10b5-1 plan
    		SELL$3,796
    1,094 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    32
    SM
    Skynner MichaelCHIEF SCIENTIFIC OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$6,739
    1,942 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    29
    TA
    Thompson Travis AlvinChief Financial Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$3,099
    893 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    29
    HF
    Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$864
    242 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    32
    LK
    Lee KevinDirector, CHIEF EXECUTIVE OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$5,848
    1,638 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    32
    LK
    Lee KevinDirector, CHIEF EXECUTIVE OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$21K
    6,167 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    32
    SM
    Skynner MichaelCHIEF SCIENTIFIC OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$1,796
    503 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    29
    TA
    Thompson Travis AlvinChief Financial Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$282
    79 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    29
    HF
    Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$5,455
    1,572 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    40
    SC
    Swanton Robert CharlesDirector
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$12K
    3,431 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    13
    PS
    Perry Jennifer ScottChief Operating Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale · 10b5-1 plan
    		SELL$1,232
    326 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    13
    PS
    Perry Jennifer ScottChief Operating Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale · 10b5-1 plan
    		SELL$285
    80 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    32
    SM
    Skynner MichaelCHIEF SCIENTIFIC OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$2,293
    532 sh
    		Jul 6, 2026Jul 7, 2026
    traded Jul 6, 2026
    		+1dSEC FORM 4

    Evidence

    22
    PS
    Perry Jennifer ScottChief Operating Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale · 10b5-1 plan
    		SELL$4,424
    1,036 sh
    		Jul 2, 2026Jul 7, 2026
    traded Jul 2, 2026
    		+5dSEC FORM 4

    Evidence

    16
    PS
    Perry Jennifer ScottChief Operating Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale · 10b5-1 plan
    		SELL$185
    43 sh
    		Jul 6, 2026Jul 7, 2026
    traded Jul 6, 2026
    		+1dSEC FORM 4

    Evidence

    16
    PS
    Perry Jennifer ScottChief Operating Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale · 10b5-1 plan
    		SELL$1,445
    333 sh
    		Jul 6, 2026Jul 7, 2026
    traded Jul 6, 2026
    		+1dSEC FORM 4

    Evidence

    38
    HF
    Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$6,431
    1,506 sh
    		Jul 2, 2026Jul 7, 2026
    traded Jul 2, 2026
    		+5dSEC FORM 4

    Evidence

    38
    TA
    Thompson Travis AlvinChief Financial Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$3,497
    819 sh
    		Jul 2, 2026Jul 7, 2026
    traded Jul 2, 2026
    		+5dSEC FORM 4

    Evidence

    38
    LK
    Lee KevinDirector, CHIEF EXECUTIVE OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$25K
    5,905 sh
    		Jul 2, 2026Jul 7, 2026
    traded Jul 2, 2026
    		+5dSEC FORM 4

    Evidence

    32
    LK
    Lee KevinDirector, CHIEF EXECUTIVE OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$7,486
    1,737 sh
    		Jul 6, 2026Jul 7, 2026
    traded Jul 6, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002015378-26-000006
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jul 6, 2026
    Published
    Jul 7, 2026
    Ingested by INSIDER
    Nov 5, 03:49 UTC
    Last re-read
    Nov 5, 03:49 UTC

    Extracted facts

    Filer
    Hannay Michael Charles Ferguson
    Role
    CHIEF PROD & SUPPLY CHAIN OFF
    Transaction
    Open-market saleAs filed: “S”
    Asset
    BICYCLE THERAPEUTICS PLC
    Ticker
    BCYC
    Shares
    255
    Price per share
    $4.31
    Value
    $1,099
    Execution date (reported)
    Jul 6, 2026
    Owned after transaction
    94.4K shares
    Days from execution to publication
    1

    Calculation

    Value = shares × reported price per share

    • Shares: 255
    • Price: $4.31

    = $1,099

    What this establishes

    Hannay Michael Charles Ferguson filed this Form 4 reporting a open-market sale of BCYC on Jul 6, 2026. It became public on Jul 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    CHIEF PROD & SUPPLY CHAIN OFF
    Hannay Michael Charles Fergusoncik:0002015378
    Issuer
    BICYCLE THERAPEUTICS PLCcik:0001761612

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.